Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.
复制标题

DOI:
10.1016/j.bcp.2010.05.019
复制
发表时间:
2010-09-15
影响因子:
5.8
通讯作者:
Wu, Jie
Wu, Jie
中科院分区:
医学2区
文献类型:
--
作者:
Chen, Liwei;Pernazza, Daniele;Scott, Latanya M.;Lawrence, Harshani R.;Ren, Yuan;Luo, Yunting;Wu, Xin;Sung, Shen-Shu;Guida, Wayne C.;Sebti, Said M.;Lawrence, Nicholas J.;Wu, Jie

文献摘要

参考文献

被引文献

相似文献

The protein tyrosine phosphatase (PTP) Shp2 (PTPN11) is an attractive target for anticancer drug discovery because it mediates growth factor signaling and its gain-of-function mutants are causally linked to leukemias. We previously synthesized SPI-112 from a lead compound of Shp2 inhibitor, NSC-117199. In this study, we demonstrated that SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2. Like some other compounds in the PTP inhibitor discovery efforts, SPI-112 was not cell permeable, precluding its use in biological studies. To overcome the cell permeation issue, we prepared a methyl ester SPI-112 analog (SPI-112Me) that is predicted to be hydrolyzed to SPI-112 upon entry into cells. Fluorescence uptake assay and confocal imaging suggested that SPI-112Me was taken up by cells. Incubation of cells with SPI-112Me inhibited epidermal growth factor (EGF)-stimulated Shp2 PTP activity and Shp2-mediated paxillin dephosphorylation, Erk1/2 activation, and cell migration. SPI-112Me treatment also inhibited Erk1/2 activation by a Gab1-Shp2 chimera. Treatment of Shp2E76K mutant-transformed TF-1 myeloid cells with SPI-112Me resulted in inhibition of Shp2E76K-dependent cell survival, which is associated with inhibition of Shp2E76K PTP activity, Shp2E76K-induced Erk1/2 activation, and Bcl-XL expression. Furthermore, SPI-112Me enhanced interferon-γ (IFN-γ)-stimulated STAT1 tyrosine phosphorylation, ISRE-luciferase reporter activity, p21 expression, and the anti-proliferative effect. Thus, the SPI-112 methyl ester analog was able to inhibit cellular Shp2 PTP activity.
DOI: 10.1152/ajpcell.00160.2009
发表时间: 2009-11-01
影响因子: 5.5
作者:
Chatterjee, Prodyot K.;Al-Abed, Yousef;Metz, Christine N.
通讯作者: Metz, Christine N.
DOI: 10.1074/jbc.m110547200
发表时间: 2002-03-15
影响因子: 4.8
作者:
Cunnick, JM;Meng, SS;Wu, J
通讯作者: Wu, J
DOI: 10.1182/blood-2005-02-0531
发表时间: 2005-09-15
期刊: BLOOD
影响因子: 20.3
作者:
Kratz, CP;Niemeyer, CM;Loh, ML
通讯作者: Loh, ML
DOI: 10.1126/science.272.5262.719
发表时间: 1996-05-03
期刊: SCIENCE
影响因子: 56.9
作者:
Chin, YE;Kitagawa, M;Fu, XY
通讯作者: Fu, XY
DOI: 10.1158/0008-5472.can-06-4293
发表时间: 2007-03-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Mulloy, Roseann;Ferrand, Audrey;Settleman, Jeffrey
通讯作者: Settleman, Jeffrey